These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37720229)

  • 1. Synthetic 5-amino-6-D-ribitylaminouracil paired with inflammatory stimuli facilitates MAIT cell expansion
    Nelson AG; Wang H; Dewar PM; Eddy EM; Li S; Lim XY; Patton T; Zhou Y; Pediongco TJ; Meehan LJ; Meehan BS; Mak JYW; Fairlie DP; Stent AW; Kjer-Nielsen L; McCluskey J; Eckle SBG; Corbett AJ; Souter MNT; Chen Z
    Front Immunol; 2023; 14():1109759. PubMed ID: 37720229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell activation by transitory neo-antigens derived from distinct microbial pathways.
    Corbett AJ; Eckle SB; Birkinshaw RW; Liu L; Patel O; Mahony J; Chen Z; Reantragoon R; Meehan B; Cao H; Williamson NA; Strugnell RA; Van Sinderen D; Mak JY; Fairlie DP; Kjer-Nielsen L; Rossjohn J; McCluskey J
    Nature; 2014 May; 509(7500):361-5. PubMed ID: 24695216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview on the identification of MAIT cell antigens.
    Kjer-Nielsen L; Corbett AJ; Chen Z; Liu L; Mak JY; Godfrey DI; Rossjohn J; Fairlie DP; McCluskey J; Eckle SB
    Immunol Cell Biol; 2018 Jul; 96(6):573-587. PubMed ID: 29656544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil.
    Ciacchi L; Mak JYW; Le JP; Fairlie DP; McCluskey J; Corbett AJ; Rossjohn J; Awad W
    J Biol Chem; 2024 May; 300(5):107229. PubMed ID: 38537698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mānuka honey-derived methylglyoxal enhances microbial sensing by mucosal-associated invariant T cells.
    Tang JS; Compton BJ; Marshall A; Anderson R; Li Y; van der Woude H; Hermans IF; Painter GF; Gasser O
    Food Funct; 2020 Jul; 11(7):5782-5787. PubMed ID: 32618294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Modulators of Mucosal Associated Invariant T Cells.
    Mak JYW; Liu L; Fairlie DP
    Acc Chem Res; 2021 Sep; 54(17):3462-3475. PubMed ID: 34415738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
    Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
    Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU).
    Li K; Vorkas CK; Chaudhry A; Bell DL; Willis RA; Rudensky A; Altman JD; Glickman MS; Aubé J
    PLoS One; 2018; 13(2):e0191837. PubMed ID: 29401462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical insights into the search for MAIT cells activators.
    Veerapen N; Hobrath J; Besra AK; Besra GS
    Mol Immunol; 2021 Jan; 129():114-120. PubMed ID: 33293098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-23 costimulates antigen-specific MAIT cell activation and enables vaccination against bacterial infection.
    Wang H; Kjer-Nielsen L; Shi M; D'Souza C; Pediongco TJ; Cao H; Kostenko L; Lim XY; Eckle SBG; Meehan BS; Zhu T; Wang B; Zhao Z; Mak JYW; Fairlie DP; Teng MWL; Rossjohn J; Yu D; de St Groth BF; Lovrecz G; Lu L; McCluskey J; Strugnell RA; Corbett AJ; Chen Z
    Sci Immunol; 2019 Nov; 4(41):. PubMed ID: 31732518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.
    Ruf B; Catania VV; Wabitsch S; Ma C; Diggs LP; Zhang Q; Heinrich B; Subramanyam V; Cui LL; Pouzolles M; Evans CN; Chari R; Sakai S; Oh S; Barry CE; Barber DL; Greten TF
    Cancer Immunol Res; 2021 Sep; 9(9):1024-1034. PubMed ID: 34193462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogens.
    Rashu R; Ninkov M; Wardell CM; Benoit JM; Wang NI; Meilleur CE; D'Agostino MR; Zhang A; Feng E; Saeedian N; Bell GI; Vahedi F; Hess DA; Barr SD; Troyer RM; Kang CY; Ashkar AA; Miller MS; Haeryfar SMM
    PLoS Pathog; 2023 Jun; 19(6):e1011485. PubMed ID: 37384813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfated bile acid is a host-derived ligand for MAIT cells.
    Ito E; Inuki S; Izumi Y; Takahashi M; Dambayashi Y; Ciacchi L; Awad W; Takeyama A; Shibata K; Mori S; Mak JYW; Fairlie DP; Bamba T; Ishikawa E; Nagae M; Rossjohn J; Yamasaki S
    Sci Immunol; 2024 Jan; 9(91):eade6924. PubMed ID: 38277465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation.
    Suliman S; Kjer-Nielsen L; Iwany SK; Lopez Tamara K; Loh L; Grzelak L; Kedzierska K; Ocampo TA; Corbett AJ; McCluskey J; Rossjohn J; León SR; Calderon R; Lecca-Garcia L; Murray MB; Moody DB; Van Rhijn I
    J Immunol; 2022 Mar; 208(6):1389-1395. PubMed ID: 35246495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and molecular modelling of new potent clickable analogues of 5-OP-RU for their use as chemical probes for the study of MAIT cell biology.
    Yvorra T; Steinmetz A; Retailleau P; Lantz O; Schmidt F
    Eur J Med Chem; 2021 Feb; 211():113066. PubMed ID: 33341648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of MR1 ligand glyco-analogues on mucosal-associated invariant T (MAIT) cell activation.
    Braganza CD; Shibata K; Fujiwara A; Motozono C; Sonoda KH; Yamasaki S; Stocker BL; Timmer MSM
    Org Biomol Chem; 2019 Oct; 17(40):8992-9000. PubMed ID: 31497838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial metabolites control the thymic development of mucosal-associated invariant T cells.
    Legoux F; Bellet D; Daviaud C; El Morr Y; Darbois A; Niort K; Procopio E; Salou M; Gilet J; Ryffel B; Balvay A; Foussier A; Sarkis M; El Marjou A; Schmidt F; Rabot S; Lantz O
    Science; 2019 Oct; 366(6464):494-499. PubMed ID: 31467190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence.
    Dey RJ; Dey B; Harriff M; Canfield ET; Lewinsohn DM; Bishai WR
    mBio; 2021 Feb; 13(1):e0386521. PubMed ID: 35164552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation.
    Schmaler M; Colone A; Spagnuolo J; Zimmermann M; Lepore M; Kalinichenko A; Bhatia S; Cottier F; Rutishauser T; Pavelka N; Egli A; Azzali E; Pieroni M; Costantino G; Hruz P; Sauer U; Mori L; De Libero G
    Mucosal Immunol; 2018 Jul; 11(4):1060-1070. PubMed ID: 29743612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient 5-OP-RU-Induced Enrichment of Mucosa-Associated Invariant T Cells in the Murine Lung Does Not Enhance Control of Aerosol Mycobacterium tuberculosis Infection.
    Vorkas CK; Levy O; Skular M; Li K; Aubé J; Glickman MS
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.